Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Celcuity Inc. (CELC)

Celcuity Q3 net loss widens to $73.3 million; no REVTORPYK revenue yet

Negative Impact 3 of 5 earnings Written later

Celcuity reported a third-quarter 2026 net loss of $73.3 million, or $1.33 per share, up from $43.8 million, or $0.92 per share, a year earlier. The company recognized no product revenue in the quarter because REVTORPYK shipments began on September 30, 2026, and revenue is recognized only on delivery, so the larger loss reflects launch spending.

Key points

  • Net loss was $73.3 million, or $1.33 per share, versus $43.8 million, or $0.92 per share, in Q3 2025.
  • No REVTORPYK product revenue was recognized in the quarter; shipments began September 30, 2026.
  • SG&A expenses rose to $39.8 million from $12.4 million, with $25.3 million of the increase tied to commercialization.
  • Cash, cash equivalents and short-term investments were $642.7 million at September 30, 2026, which the company expects will fund operations through 2029.

The filing

CompanyCelcuity Inc. (CELC)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:05 PM ET
Accession number0001193125-26-449757

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.